Physician

James Edward Renehan, MD

According to 2025 Medicare claims, James Renehan, MD (NPI: 1386607117) practices urology in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is ADVANCED UROLOGY INSTITUTE, LLC (NPI: 1023447935; TIN: 46-2439971) and primary practice location at 32308-4894. Renehan is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Renehan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 867 traditional Medicare patients, billed 19,915 HCPCS/CPT codes, and received $331,463 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 5,833 prescription claims across 1,224 beneficiaries totaling $860,302 in drug costs, led by Myrbetriq (Mirabegron). DME data shows 102 claims. Open Payments data shows 46 records totaling $1,028. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $226,552 to $860,302. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $1,153 to $522.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	793	19,001	$217,240
2016	851	14,596	$232,726
2017	861	15,357	$230,508
2018	922	17,194	$251,117
2019	1,023	22,354	$256,400
2020	873	18,268	$257,927
2021	813	16,361	$209,220
2022	762	13,532	$265,369
2023	862	21,260	$266,086
2024	867	19,915	$331,463

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	477	2,419	$226,552
2016	540	2,905	$324,265
2017	553	3,237	$355,232
2018	640	3,374	$361,042
2019	751	3,991	$405,584
2020	794	4,148	$469,745
2021	777	3,866	$454,602
2022	839	4,217	$628,577
2023	982	4,599	$785,342
2024	1,224	5,833	$860,302

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	93	$25,855
2016	N/R	103	$23,630
2017	N/R	72	$20,917
2018	N/R	22	$6,326
2019	N/R	42	$30,202
2020	N/R	106	$58,097
2021	N/R	116	$57,669
2022	N/R	109	$59,078
2023	N/R	98	$53,482
2024	N/R	102	$50,187

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	674	1,190	$99
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	463	691	$13
51798	Ultrasound measurement of bladder capacity after voiding	205	290	$8
36415	Insertion of needle into vein for collection of blood sample	263	390	$7
81003	Automated urinalysis test	633	1,008	$2

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	748	41,423	$601,609
Gemtesa	Vibegron	107	6,870	$104,526
Tamsulosin Hcl	Tamsulosin Hcl	1,346	112,287	$28,516
Silodosin	Silodosin	165	12,018	$14,759
Solifenacin Succinate	Solifenacin Succinate	399	30,595	$14,508

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	N/R	33	$30,927
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	N/R	53	$19,034
A4332	Lubricant, individual sterile packet, each	N	N/R	16	$226

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	44	$1,028	PROCEPT BioRobotics Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	2	$14,921	SN Holdings, LLC

Explore More Providers

FAQ

What Medicare data is available for James Edward Renehan, MD?

Tedicare shows public-source Medicare data for James Edward Renehan, MD (NPI 1386607117), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does James Edward Renehan, MD have ACO affiliation data?

James Edward Renehan, MD is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to James Edward Renehan, MD?

James Edward Renehan, MD is linked to ADVANCED UROLOGY INSTITUTE, LLC (billing NPI 1023447935) in the available physician profile data.

Does James Edward Renehan, MD have Open Payments data?

James Edward Renehan, MD has 46 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.